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Protein kinase CIt has been shown that cholesterol modulates activity of protein kinase C (PKC), and PKC phosphorylates
connexin 43 (Cx43) to regulate its function, respectively. However, it is not known whether cholesterol
modulates function of Cx43 through regulating activity of PKC. In the present study, we demonstrated that
cholesterol enrichment reduced the dye transfer ability of Cx43 in cultured H9c2 cells. Western blot analysis
indicated that cholesterol enrichment enhanced the phosphorylated state of Cx43. Immunoﬂuorescent images
showed that cholesterol enrichment made the Cx43 distribution from condensed to diffused manner in the
interface between the cells. In cholesterol enriched cells, PKC antagonists partially restored the dye transfer
ability among the cells, downregulated the phosphorylation of Cx43 and redistributed Cx43 from the diffused
manner to the condensed manner in the cell interface. In addition, reduction of cholesterol level suppressed
PKC activity to phosphorylate Cx43 and restored Cx43 function in PKC agonist-treated cells. Furthermore, we
demonstrated that cholesterol enrichment upregulated the phosphorylated state of Cx43 at Ser368, while PKC
antagonists reversed the effect. Taken together, cholesterol level in the cells plays important roles in regulating
Cx43 function through activation of the PKC signaling pathway.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Connexins assemble to form gap junction channels to mediate
communication and signaling between adjacent cells by allowing the
passage of ions, metabolites and signaling molecules. Connexins
interact with caveolins and partition into lipid raft domains [1] such
thatmembrane cholesterol plays a signiﬁcant role in regulating function
of gap junction channels [2,3]. Connexin43 (Cx43) is predominantly
expressed in the heart where it supports the spread of the action
potential that ensures the coordinated contractile activation of the
heart. The normal heart rhythm thus depends fundamentally on
the coupling of gap junctions in cardiomyocytes. In cholesterol-fed
rabbits, elevated cholesterol level results in redistribution of Cx43
gap junctions at the lateral membrane of cardiomyocytes, suggesting that
Cx43 is involved in the molecular mechanism of hypercholesterolemia-
induced cardiac contractile dysfunction and dysrhythmias [4].
Recently, it has been indicated that loss of cardioprotection by
ischemic preconditioning in cholesterol dieted rats is associated
with a redistribution of both sarcolemmal and mitochondrial Cx43xmu.edu.cn (Z. Qi).[5]. These pieces of evidence imply that cholesterol might regulate
the function of the Cx43 gap junction channel.
Activation of protein kinase C (PKC) can lead to phosphorylation of
Cx43, which affects trafﬁcking, assembly, degradation, and channel
gating of Cx43 gap junction channels [6–8]. On the other hand, choles-
terol induces activation of PKC in cultured ascites tumor cells [9] and
cholesterol-fed rabbits exhibited an increase in PKC activity in smooth
muscle cells [10]. In addition, it has been demonstrated that cholesterol
can amplify the activity of PKC in the presence of diacylglycerol [11].
Therefore, we hypothesize that cholesterol can regulate the function
of Cx43 through a PKC dependent pathway. In the present study,
using methly-β-cyclodextrin (MβCD) to manipulate membrane
cholesterol content, we studied the effect of cholesterol on the function
and distribution of Cx43 in H9c2 cell line, a standard cardiac cell line
derived fromembryonic cells. Our results demonstrated that cholesterol
plays an important role in modulating the function of the Cx43 gap
junction channel through a PKC-dependent pathway.
2. Materials and methods
2.1. Materials
Staurosporine (STS), ﬁlipin, DAPI, MβCD, cholesterol loaded MβCD
(MβCD/Chol) and rabbit anti-Cx43 antibody were from Sigma-Aldrich.
2020 J. Zou et al. / Biochimica et Biophysica Acta 1838 (2014) 2019–2025PBS, FBS and HBSS were from Gibco. PMA solution was from
MultiSciences Biotech. Calphostin Cwas fromMerck Biosciences. Lucifer
yellowwas fromMolecular probes. Phospho-Connexin 43 (Ser368)was
from Cell Signaling.
2.2. Cell culture
Rat embryonic ventricular cell line H9c2 (Chinese Academy of
Sciences Cell Bank, Shanghai) was cultured in Dulbecco's modiﬁed
eagle's medium (DMEM) supplemented with 10% fetal bovine serum
(FBS), 100 units/mL penicillin G, and 100 mg/mL streptomycin at
37 °C in a humidiﬁed atmosphere of 5% CO2. The mediumwas changed
every 2–3 days and the cells were subcultured regularly. For experi-
ments, cells were cultured on 6-well plates, kept in DMEM with
10% FBS until 80%–90% conﬂuence.
2.3. Western blotting
The cultured H9c2 cells were homogenized on ice in lysis buffer
(8 mol/L urea, 1 mmol/L dithiothreitol, 1 mmol/L EDTA, 50 mmol/L
Tris–HCl, pH = 8.0, supplemented with a proteinase inhibitor cocktail
(Sigma) and sonicated three times for 10 s on ice. The protein in the
samples was quantiﬁed by Bradford's method. Western blotting was
performed as described previously [12]. A 10 μg sample of each protein
was loaded onto 10% sodium dodecyl sulfate-polyacrylamide gel and
the bandwas transferred to the PVDFmembrane (Millipore). Themem-
branes were preincubated with 5% skim milk in PBS containing 0.05%
Tween 20 for 1 h, then incubated with 1:10,000 anti-connexin43
(Sigma) and 1:1000 anti-GAPDH (Epitomics) antibody overnight. After-
wards themembranes were washed in PBS containing 0.05% Tween 20,
followed by incubation with anti-rabbit immunoglobulin-conjugated
peroxidaselabeled dextran polymer (1:1000, Jackson) for 1 h at room
temperature. The immunoreactivity was visualized by use of an ECL
plus western blotting detection system (Millipore). Densitometric
analyseswere performedwith Adobe photoshop7.0.1 software package.
2.4. Immunoﬂuorescence analysis
The H9c2 cells cultured on six-well glass chamber slides were ﬁxed
in 4% paraformaldehyde in PBS for 5 min, permeabilized with 0.5%
Triton X-100 in PBS for 5min, and stainedwith antibodies. For immuno-
ﬂuorescence analysis, rabbit anti-Cx43 antibody (1:400) was applied as
primary antibodies. The sections were blocked with 5% goat serum, in-
cubated with antibodies diluted in blocking reagent overnight at 4 °C.
Afterwards, the sections were washed 3 times in TBST buffer and
incubated with DyLight549 goat anti-rabbit immunoglobulin (Jackson)
for 1 h at room temperature. Nuclei were stainedwith DAPI. Slices were
mountedwith antifademountingmedium (Beyotime, Shanghai, China)
and analyzed using Olympus confocal microscope (FV 1000).
2.5. Fluorescent dye transfer assay of gap junction activity
The H9c2 cells were bathed in Hanks' balanced salts solution (HBSS,
Gibco, inmM): 1.3 CaCl2, 0.8MgSO4, 5.4 KCl, 0.4 KH2PO4, 136.9 NaCl, 0.3
Na2PO4, 10 D-glucose and 4.2 NaHCO3. The pH and osmolarity of the
bath and the pipette ﬁlling solution were adjusted to 7.4 and
295 mOsmol/L, respectively. Microelectrodes (tip diameter, ~1 μm)
were pulled from capillaries and backﬁlled with Lucifer yellow (0.5%)
dissolved in the pipette ﬁlling solution (in mM): 100 K-gluconate, 40
KCl, 5 Na2ATP, 2.5 MgCl2, 0.25 CaCl2, 1 BAPTA, 0.2 cGMP, 1 glucose and
10 HEPES. Whole-cell patch-clamp conﬁguration was established on
one of the H9c2 cells within the monolayer on a cover slip, where the
cells were grown to over 90% conﬂuence. Pipette ﬁlling solution con-
taining 0.5% Lucifer yellow was allowed to directly diffuse into the cell
under whole-cell conﬁguration and through the gap junction channels
into the adjacent cells. Ten minutes after establishment of the wholecell conﬁguration, the number of dye-coupled cells was counted using
a ﬂuorescencemicroscope to judge the activity of the Cx43 gap junction
channels. MβCD or MβCD/Chol was used to increase or deplete the
cholesterol content of the cells [13].
2.6. Statistical analysis
All data were shown as mean ± s.e.m. Data were analyzed statisti-
cally by one-way analysis of variance (ANOVA) followed by the
Bonferroni test for multiple comparisons. Origin7.0 (Microcal Software,
Inc.) or Prism5.0 (GraphPad Software, Inc) softwarewas used for statis-
tical analyses. Values of P b 0.05 were considered to be statistically
signiﬁcant.
3. Results
3.1. Effect of cholesterol enrichment on phosphorylation, distribution and
function of Cx43
First, we studied the effect of cholesterol enrichment on the
function of Cx43 in cultured H9c2 cells. The function of Cx43 was
evaluated by means of dye transfer ability following the intracellu-
lar microinjection of Lucifer yellow. Enrichment of cholesterol by
1 hour exposure of 50 μM cholesterol-loaded MβCD (MβCD/Chol)
reduced the dye transfer ability of Cx43 (Fig. 1A). In untreated
cells, the injected dye spread into 19.9 ± 1.2 (n = 10) cells, while
the dye spread into only 5.1 ± 0.6 (n = 10) cells in the cholesterol
enriched cells (Fig. 1 C). Immunostaining images of the cell probed
with anti-Cx43 antibody revealed that the cholesterol enrichment
redistributed Cx43 at the boundaries between the cells from a con-
densedmanner for the control (e.g., thewhite arrow in Fig. 1B1) to a dis-
persed manner for the cholesterol enriched cells (e.g., the white arrow
in Fig. 1B2). This result suggested that cholesterol enrichment caused
the redistribution of Cx43 and disassembly of the Cx43 gap junction
channels, resulting in the reduction of the dye transfer ability. Western
blot analysis indicated that the cholesterol enrichment promoted phos-
phorylation of Cx43 (p-Cx43) in a dose-dependent manner (Fig. 1D):
the phosphorylated Cx43 was signiﬁcantly increased, while the expres-
sion level of control protein GAPDH was unchanged with increasing
concentration of MβCD/Chol from 0, 2, 5, 10 to 50 μM. This result is in
good agreement with a previous report that cholesterol-enriched diet
results in redistribution of Cx43 gap junctions at the lateral cell mem-
brane [4], suggesting that cholesterol enrichment could decrease dye
transfer ability and increase p-Cx43 level in cultured H9c2 cells.
3.2. PKC antagonists increased dye transfer ability and reduced p-Cx43 level
in cholesterol enriched cells
Next, to testwhether PKC is involved in the reduction of dye transfer
ability of Cx43 in the cholesterol enriched cells,we used broad spectrum
PKC antagonists, STS and calphostin C, to block the effect of PKC. In the
cholesterol enriched cells, the dye spread into only 5.1 ± 0.6 (n= 10)
cells. STS (10 nM) and calphostin C (100 nM) increased the number of
dye-coupled cells to 12.0 ± 1.1 (n=5) and 17.4± 2.0 (n=5), respec-
tively (Fig. 2A and C). Immunoﬂuorescent images showed that both STS
and calphostin C redistributed Cx43 from the diffused manner (e.g.,
white arrows in Fig. 2B1) to the condensed manner (e.g., white arrows
in Fig. 2B2–3) in the interfaces between the cholesterol enriched cells.
Furthermore, western blot analysis indicated that both STS and
calphostin C reduced the p-Cx43 level (Fig. 2D and E) in the cholesterol
enriched cells. In contrast, STS and calphostin C alone had no signiﬁcant
effect on the dye-coupling ability, Cx43 distribution, Cx43 expression
and p-Cx43 level in the untreated cells (Fig. 3). Thus, PKC antagonists
could increase dye transfer ability, and reduce the p-Cx43 level in the
cholesterol enriched cells.
Fig. 1. Cholesterol enrichment decreased dye transfer ability and increased phosphorylated Cx43 (p-Cx43) level in cultured H9c2 cells. (A) Representative ﬂuorescent image of dye-
couplingbetween the cells in the absence (1) andpresence (2) of 50 μMMβCD/Chol for 1 h. TheH9c2 cellswere grown to over 90% conﬂuence. Dotted line: dye-coupled cells. Red asterisk:
dye injected cell. (B) Representative immunoﬂuorescent images of Cx43 (red). Nuclei: blue (DAPI). The area indicated by the white arrows is ampliﬁed as black and white images in the
upright corner of the images. (C) Statistical summary for the number of dye coupled cells in the absence and presence of 50 μM MβCD/Chol. (D) Representative western blot and
densitometric analyses of p-Cx43/Cx43 at control condition and in the presence of 2, 5, 10 and 50 μMMβCD/Chol. *: P b 0.05, **: P b 0.01 (vs. control).
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p-Cx43 level in cells pre-treated with PKC agonist
To further conﬁrm the involvement of PKC in the effect of cholesterol
on Cx43, we applied PKC agonist phorbol 12-myristate 13-acetate
(PMA) to the H9c2 cells. With increasing concentration of PMA from
5, 10 to 20 nM, the p-Cx43 level was signiﬁcantly increased (Fig. 4D).
Phosphorylation of Cx43 has been shown to be responsible for Cx43 dis-
assembly and reduction of dye transfer ability of the cells [7,8,14–16].
Thus, when PMA (50 nM) was added, PMA reduced the number ofFig. 2. PKC antagonist increased dye transfer ability and reduced p-Cx43 level in cholesterol en
munoﬂuorescent image of Cx43 with the white arrows indicated the changes of the Cx43 distr
30 min). Dotted line: dye-coupled cells. Red asterisk: dye injected cell. Bar = 50 μm. (C) Stat
of p-Cx43/Cx43. Cells were treated with 50 μMMβCD/Chol for 30 min, then different conce
group), #: P b 0.05 (vs. MβCD/Chol group).dye-coupling cells from 19.9 ± 1.2 (n= 10) of the control (Fig. 1C) to
1.4 ± 0.3 (n = 10) in PMA treated cells (Fig. 4 C). However, reduction
of the cholesterol level with MβCD could prevent the PMA induced
reduction of the dye coupling between the cells (comparing Fig. 4A1
and A3). The number of dye-coupling cells could be increased from
1.4 ± 0.3 in PMA treated cells to 4.3 ± 0.8 (n = 8) in PMA + MβCD
treated cells (Fig. 4C). To further conﬁrm this result, we administered
fenoﬁbrate (Feno), a PPar-α activator, which are widely used in the
treatment of hyperlipidemia and effective in lowering the cholesterol
levels [17,18]. As shown in Fig. 4A2 and C, the number of dye-coupledriched H9c2 cells. (A, B) Fluorescent image of dye-coupling between the cells (A) and im-
ibution (B) in the absence and presence of STS (10 nM, 30 min) or calphostin C (100 nM,
istical summary for dye coupled cells. (D, E) Western blot and densitometric analyses
ntrations of STS or calphostin Cwere applied for another 30 min. ***: P b 0.001 (vs. control
Fig. 3. Effect of PKC antagonists on dye transfer and p-Cx43 level in cultured H9c2 cells. (A, B) Fluorescent images for dye coupling between the cells (A) and immunoﬂuorescent image of
Cx43 with the white arrows indicating Cx43 distribution (B) in the absence and presence of 10 nM STS or 100 nM calphostin C. Dotted line: dye-coupled cells. Red asterisk: dye injected
cell. Bar = 50 μm. (C, D) Statistical summary for dye coupled cells (C) and western blot for Cx43/p-Cx43 (D) in the absence and presence of STS and calphostin C.
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(n = 8) in PMA + Feno treated cells (Fig. 4C). This is accompanied
by restoration of Cx43 distribution from a dispersed manner (e.g.,
white arrows in Fig. 4B2) to a condensed manner (e.g., white arrows
in Fig. 4B3) between the boundaries of the cells. Furthermore, appli-
cation of MβCD (10 mM) or Feno reduced the p-Cx43 level in the
PMA pre-treated cells (Fig. 4D). In contrast, the cholesterol deple-
tion alone (10 mM MβCD or 100 μM Feno) led to the reduction of
the dye transfer ability of the Cx43 gap junction among cells
(Fig. 5A and B). Therefore, cholesterol depletion could increase the
dye transfer ability and decrease the p-Cx43 level in the PMA pre-
treated cells.Fig. 4. Reduction of the cholesterol level increased dye transfer ability and decreased the p-Cx4
(A) and immunoﬂuorescent image of Cx43 with the white arrows indicated the changes of the
asterisk: dye injected cell. Bar = 50 μm. (C) Statistical summary for dye coupled cells. (D) W
30 min or Feno for 11.5 h, followed by treatment with PMA for another 30 min. *: P b 0.05, **:3.4. Cholesterol enrichment upregulated the phosphorylated state of
Cx43 at Ser368 through the PKC signaling pathway
It has been shown that activation of PKC causes phosphorylation of
Cx43 at Ser368, which leads to disassembly of Cx43 and results in the
reduction of the dye transfer ability of the cells [7,14,16]. The above re-
sults indicated that cholesterol could modulate the function of the Cx43
gap junction channel via the PKC signaling pathway. Therefore, we test-
ed whether phosphorylation of Ser368 by PKC was responsible for the
cholesterol regulation of Cx43. Fig. 6A showed that phosphorylation of
Cx43 at Ser368 was signiﬁcantly increased upon cholesterol enrich-
ment. In contrast, in the presence of PKC antagonists, the cholesterol3 level in PKC agonist treated cells. (A, B) Fluorescent image of dye-coupling between cells
Cx43 distribution (B) under the indicated conditions. Dotted line: dye-coupled cells. Red
estern blot and densitometric analyses of p-Cx43/Cx43. Cells were pre-treated MβCD for
P b 0.01, ***: P b 0.001 (vs. control). #: P b 0.05 (vs. 20 nM PMA group).
Fig. 5.Effect of cholesterol depletion on dye transfer and p-Cx43 level inH9c2 cells. (A, B) Fluorescent images (A) and statistical summary (B) for dye couplingbetween theH9c2 cells in the
absence andpresence of cholesterol lowering agents (20mMMβCD, 1 h or 100 μMFeno, 12 h). Dotted line: dye-coupled cells. Red asterisk: dye injected cell. (C) Immunoﬂuorescent image
of Cx43with the white arrows indicated the changes of the Cx43 distribution in the absence and presence of MβCD. (D)Western blots and densitometric analyses of p-Cx43/Cx43 in the
presence of 20 mMMβCD (30 min). Bar = 50 μm.*: P b 0.05, **: P b 0.01. ***: P b 0.001 (vs. control).
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other hand, PKC agonist PMA signiﬁcantly increased the Cx43 phos-
phorylation at Ser368 that could be downregulated by depletion of cho-
lesterol level with MβCD or Feno (Fig. 6B). These results demonstrated
that cholesterol couldmodulate the function of Cx43 gap junction chan-
nel by enhancing the phosphorylation of Cx43 at Ser368 via the PKC
pathway.
4. Discussion
In this work we demonstrated that cholesterol could modulate the
function of the Cx43 gap junction channel by enhancing phosphoryla-
tion of Cx43 at Ser368 residue through the PKC signaling pathway,
which is supported by the following pieces of evidence: 1) cholesterol
enrichment increased thep-Cx43 level that could be reduced by PKCan-
tagonists; 2) cholesterol enrichment decreased dye transfer ability that
could be reversed by treatment of PKC antagonists; 3) cholesteroldepletion increased dye transfer ability and decreased the p-Cx43
level in the cells pre-treated with the PKC agonist; 4) the p-Cx43 level
at Ser368 upregulated by cholesterol enrichment could be downregu-
lated by PKC antagonists. In consistence with our results, cholesterol
supplementation has been shown to increase PKC activity [9] and a
high level of PKC activity has been demonstrated in smooth muscle
cells obtained from the aorta of cholesterol-fed rabbits [10]. Even
though Cx43 is phosphorylated at multiple residues [21], PKC phos-
phorylates Cx43 mainly at Ser368 residue [22]. And phosphorylation
of Cx43 at Ser368 is negatively correlated with gap junction assembly
and reduces the cell-to-cell communication [14,15,23]. Furthermore,
the HDL particle has been shown to promote phosphorylation of Cx43,
which can be inhibited by pre-treatment with PKC inhibitors [8]. Inter-
estingly, simvastatin, one of the cholesterol-lowering lipophilic statins,
can enhance gap junction coupling by decreasing PKC-mediated Cx43
phosphorylation [24]. These results suggested that cholesterol could en-
hance the activity of PKC to phosphorylate Cx43 at Ser368, resulting in
Fig. 6. Cholesterol enrichment upregulated the phosphorylated state of Cx43 at Ser368 through the PKC signaling pathway. (A) Effect of MβCD/Chol, MβCD/Chol + STS and
MβCD/Chol + calphostin C on the phosphorylated state of Cx43 at Ser368. *: P b 0.05 (vs. control). #: P b 0.05, ##: P b 0.01 (vs. MβCD/Chol group). (B) Effect of PMA,
PMA +MβCD and PMA + Feno on the phosphorylated state of Cx43 at Ser368. **: P b 0.01 (vs. control). #: P b 0.05, ###: P b 0.001 (vs. PMA group). Upper panel: Western
blot. Lower panel: statistics summary for ratio between Ser368 phosphorylation and GAPDH.
2024 J. Zou et al. / Biochimica et Biophysica Acta 1838 (2014) 2019–2025Cx43 gap junction disassembly and reduction of the cell-to-cell
communication.
Then, how does cholesterol enhance PKC activity? Cholesterol has
been shown to affect membrane protein structure and function both
by binding directly to speciﬁc binding sites on the protein and by chang-
ing various biophysical properties of the bilayer [25]. It is known that
PKC activity is dependent on the nature of the membrane environment
[26–28]. In their series studies [11,27–29], Zidovetzki et al. demonstrat-
ed that PKC activity can be increased by lipophilic compounds that can
destabilize bilayers by increasing their propensity to adopt the
nonbilayer lipid phase. In the phosphatidylcholine/phosphatidylserine
bilayer system, ampliﬁed PKC activity was observed in the presence of
both cholesterol and diacylglycerol [11]. Cholesterol has small polar
headgroup and large hydrophobic body. Molecular dynamic simulation
of the lipid bilayer membrane has demonstrated that to avoid the unfa-
vorable exposure of the hydrophobic part to water, neighboring phos-
pholipid headgroups move toward cholesterol [30]. Therefore, as
suggested by 2H NMR measurements, ampliﬁcation of the PKC activity
by cholesterol is due to the ability of cholesterol to induce propensity
of the lipids to adopt nonbilayer phases, leading to destabilization of
the bilayer structure [11]. As Ser368 of Cx43 is the main target residue
of PKC, upregulated PKC activity could lead to an increase in the p-Cx43
level and a decrease in the cell-to-cell communication.
Cholesterol enrichment decreased dye transfer ability and in-
creased p-Cx43 level in cultured H9c2 cells (Fig. 1). Paradoxically,
cholesterol depletion (10 mM MβCD or 100 μM Feno) led to the re-
duced dye transfer ability of Cx43 gap junction among cells as well
(Fig. 5A and B). However, western blot analysis indicated that the
cholesterol depletion reduced p-Cx43 in a dose-dependent manner
(Fig. 5D), which was opposite to that of the cholesterol enrichment.
Furthermore, immunoﬂuorescent images showed that the cholesterol
depletion reduced the amount of Cx43 protein to distribute along the
boundaries between the cells (Fig. 5C) rather than making Cx43
distribute in a dispersedmanner as done by the cholesterol enrichment,
suggesting different mechanisms responsible for the reduced diffusion
of ﬂuorescent dye among cells for enrichment and depletion of choles-
terol. Cholesterol depletion reduced the amount of Cx43 in the interface
between the cells, whichmight be the reasonwhy the dye transfer abil-
ity of Cx43 was reduced, while cholesterol enrichment promoted the
phosphorylation of Cx43, leading to the disassembly of Cx43 gap junc-
tion channel and resulting in reduced dye transfer ability.
Cholesterol is the principal constituent of lipid rafts. Its removal from
the cell membrane would disrupt the integrity of the raft [19], thereby
leading to a loss of functions mediated by these domains. Connexinsthat are the structural proteins of gap junctions are preferentially local-
ized in the lipid rafts of the plasma membrane [1,16,20], which are
enriched in cholesterol and sphingolipids. It has been demonstrated
thatmembrane cholesterol plays a signiﬁcant role in regulating function
of gap junction channels [2,3]. Cx43 speciﬁcally targets lipid rafts by di-
rectly interacting with caveolin-1 [1]. It has been demonstrated that
Cx43 is redistributed within the lipid rafts once phosphorylated by
PKC at Ser368, leading to the disassembly of Cx43 out of cell junction
plaques and resulting in the inhibition of dye transfer [16]. In our
study, MβCD could suppress PMA activated PKC activity to phosphory-
late Cx43 and restore Cx43 function. As MβCD is generally used to
disrupt lipid raft [13], it is possible thatMβCD takes action by disrupting
the raft. On the other hand, Feno that has not been reported to disrupt
lipid raft could suppress the PMA upregulated p-Cx43 level and restore
the dye transfer ability of the cells, suggesting that it is cholesterol
rather than raft that plays an important role in regulating Cx43
function. In agreement with this suggestion, it has been shown that
cholesterol could amplify PKC activity in the phosphatidylcholine/
phosphatidylserine bilayer system [11], where there is no lipid raft.
Obviously, further works need to be done to address this issue.
Previously, it has been demonstrated that PKC can spatially and tem-
porally regulate gap junctional communication [14,15,23]. On the
other hand, it has been shown that cholesterol plays an important
role in the proper function of Cx43 [2,4]. However, it is not known
whether the cholesterol level regulates the function of gap junctional
communication via the PKC signaling pathway. Our study added new
information by demonstrating that it is through the PKC pathway to
phosphorylate Cx43 at Ser368 that cholesterol levels could modulate
the function of the Cx43 gap junction channel.Acknowledgments
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